SCHEMBL12760596

SCHEMBL12760596

CC(C)COC(=O)N1CC[C@@H](CN)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.44
JAK1 P23458 4/20 0.43
JAK2 O60674 3/20 0.43
HSD11B1 P28845 1/20 0.42
TPSAB1 Q15661 1/20 0.40
TPSD1 Q9BZJ3 1/20 0.40
TPSG1 Q9NRR2 1/20 0.40
GAA P10253 1/20 0.40
NOS3 P29474 1/20 0.38
NOS2 P35228 1/20 0.38
GPR119 Q8TDV5 1/20 0.36
HDAC2 Q92769 1/20 0.35
PIK3CD O00329 1/20 0.35
MEN1 O00255 1/20 0.35
HPGD P15428 1/20 0.35
KMT2A Q03164 1/20 0.35
DPP8 Q6V1X1 1/20 0.35
DPP7 Q9UHL4 1/20 0.35
CHRM2 P08172 2/20 0.35
CHRM1 P11229 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2012460 1.00 RAB9A (0.44) RAB9AJAK1JAK2HSD11B1TPSAB1
SCHEMBL5262093 0.91 RAB9A (0.49) RAB9AJAK1JAK2HSD11B1TPSAB1
SCHEMBL2894884 0.91 TPSAB1 (0.47) RAB9AJAK1JAK2HSD11B1TPSAB1
SCHEMBL5568829 0.89 RAB9A (0.43) RAB9AJAK1JAK2HSD11B1GAA
SCHEMBL4687962 0.86 RAB9A (0.46) RAB9AJAK1JAK2HSD11B1GAA
SCHEMBL4685564 0.85 RAB9A (0.44) RAB9AJAK1JAK2HSD11B1GAA
SCHEMBL4594562 0.84 RAB9A (0.43) RAB9AJAK1JAK2HSD11B1GAA
SCHEMBL27357653 0.84 RAB9A (0.43) RAB9AJAK1JAK2HSD11B1GAA
SCHEMBL14405029 0.84 RAB9A (0.47) RAB9AJAK1JAK2HSD11B1GAA
SCHEMBL3825100 0.82 HSD11B1 (0.43) RAB9AJAK1JAK2HSD11B1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2503890-A1 AZABENZIMIDAZOLES AS FATTY ACID SYNTHASE INHIBITORS GlaxoSmithKline LLC (US) 2012-10-03 EP disclosed